<GlossaryTerm id="CDR0000367460"><TermName>nelarabine</TermName><TermPronunciation>(neh-LAR-uh-been)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat adults and children aged 1 year and older with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. It is used in patients whose cancer has not gotten better or has recurred (come back) after treatment with other anticancer drugs. Nelarabine stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite. Also called 506U78 and Arranon.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000711218" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;nelarabine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000711219" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;nelarabina&quot;" language="es" id="_4"/><SpanishTermName>nelarabina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para el tratamiento de adultos y niños de 1 año o más con leucemia linfoblástica aguda de células T o linfoma linfoblástico de células T. Se emplea en pacientes cuyo cáncer no mejoró o recidivó (volvió) después del tratamiento con otros medicamentos contra el cáncer. La neralabina evita que las células elaboren ADN y es posible que destruya células cancerosas. Es un tipo de antimetabolito. También se llama 506U78 y Arranon.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-04-23</DateFirstPublished><DateLastModified>2020-12-29</DateLastModified><RelatedInformation><RelatedDrugSummaryRef UseWith="en" href="CDR0000492016" url="/about-cancer/treatment/drugs/nelarabine">Nelarabine</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
